Abstract:The number of people suffering from hair loss is increasing, and hair loss occurs not only in older men but also in women and young people. Prostaglandin D2 (PGD2) is a well-known alopecia inducer. However, the mechanism by which PGD2 induces alopecia is poorly understood. In this study, we characterized CXXC5, a negative regulator of the Wnt/β-catenin pathway, as a mediator for hair loss by PGD2. The hair loss by PGD2 was restored by Cxxc5 knock-out or treatment of protein transduction domain–Dishevelled binding motif (PTD-DBM), a peptide activating the Wnt/β-catenin pathway via interference with the Dishevelled (Dvl) binding function of CXXC5. In addition, suppression of neogenic hair growth by PGD2 was also overcome by PTD-DBM treatment or Cxxc5 knock-out as shown by the wound-induced hair neogenesis (WIHN) model. Moreover, we found that CXXC5 also mediates DHT-induced hair loss via PGD2. DHT-induced hair loss was alleviated by inhibition of both GSK-3β and CXXC5 functions. Overall, CXXC5 mediates the hair loss by the DHT-PGD2 axis through suppression of Wnt/β-catenin signaling.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the mechanism of androgenetic alopecia, especially the hair loss problems caused by prostaglandin D2 (PGD2) and dihydrotestosterone (DHT). Specifically, the researchers hope to clarify the following points: 1. **The role of CXXC5 in PGD2 - induced hair loss**: It is known that PGD2 is an important factor leading to hair loss, but its specific mechanism is still unclear. The researchers have experimentally verified that CXXC5, as a negative regulator of the Wnt/β - catenin signaling pathway, plays a key role in the process of PGD2 - induced hair loss. 2. **The relationship between CXXC5 and the Wnt/β - catenin signaling pathway**: The Wnt/β - catenin signaling pathway is crucial for the development, maintenance and regeneration of hair follicles. The study found that CXXC5 inhibits the Wnt/β - catenin signaling pathway, causing the hair follicles to enter the catagen phase, thus triggering hair loss. 3. **The mechanism of DHT - induced hair loss through the CXXC5 and PGD2 axis**: The study further revealed that DHT activates GSK - 3β, which in turn up - regulates PTGDS (prostaglandin D2 synthase), ultimately leading to an increase in CXXC5 expression, inhibiting the Wnt/β - catenin signaling pathway, and thus triggering hair loss. 4. **Potential treatment strategies**: The researchers proposed that by inhibiting the functions of CXXC5 and GSK - 3β, the hair loss caused by DHT and PGD2 can be effectively restored, providing a new treatment direction for androgenetic alopecia. ### Key conclusions - CXXC5 mediates PGD2 - induced hair loss by inhibiting the Wnt/β - catenin signaling pathway. - DHT inhibits the Wnt/β - catenin signaling pathway by up - regulating PTGDS and CXXC5, leading to hair loss. - Inhibiting the functions of CXXC5 and GSK - 3β can effectively alleviate the hair loss caused by DHT and PGD2. These findings not only deepen the understanding of the mechanism of androgenetic alopecia, but also provide a theoretical basis for the development of new treatment methods.

CXXC5 Mediates DHT-Induced Androgenetic Alopecia via PGD2

The PD-1/PD-L1 Pathway in Murine Hair Cycle Transition: a Potential Anagen Phase Regulator

CircAGK regulates high dihydrotestosterone‐induced apoptosis in DPCs through the miR‐3180‐5p/BAX axis

Anti-Hair Loss Effects of the DP2 Antagonist in Human Follicle Dermal Papilla Cells

Dihydrotestosterone Regulates Hair Growth Through the Wnt/β-Catenin Pathway in C57BL/6 Mice and In Vitro Organ Culture

Epigallocatechin Gallate-Mediated Alteration of the MicroRNA Expression Profile in 5α-Dihydrotestosterone-Treated Human Dermal Papilla Cells

Cyanidin 3-O-arabinoside suppresses DHT-induced dermal papilla cell senescence by modulating p38-dependent ER-mitochondria contacts

Effects of Camellia oleifera seed shell polyphenols and 1,3,6-tri-O-galloylglucose on androgenic alopecia via inhibiting 5a-reductase and regulating Wnt/β-catenin pathway

Efficacy of Asymmetric siRNA Targeting Androgen Receptors for the Treatment of Androgenetic Alopecia

Ginsenoside F2 reduces hair loss by controlling apoptosis through the sterol regulatory element-binding protein cleavage activating protein and transforming growth factor-β pathways in a dihydrotestosterone-induced mouse model.

Effects of Camellia Oleifera Seed Shell Polyphenols and 1,3,6-Tri-o-galloyl-glucose on Androgenic Alopecia Via Inhibiting 5A-Reductase and Regulating Wnt/(3-catenin Pathway

Hair follicle stem cell differentiation is inhibited through cross-talk between Wnt/β-catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia

Panax ginseng extract antagonizes the effect of DKK-1-induced catagen-ike changes of hair follicles

Botulinum Toxin Type A Alleviates Androgenetic Alopecia by Inhibiting Apoptosis of Dermal Papilla Cells via Targeting circ_0135062/miR-506-3p/Bax Axis

Transcriptome Analysis Reveals an Inhibitory Effect of Dihydrotestosterone-Treated 2D- and 3D-Cultured Dermal Papilla Cells on Hair Follicle Growth

Ginsenoside CK inhibits androgenetic alopecia by regulating Wnt/β‐catenin and p53 signaling pathways in AGA mice

Bioactives in Chinese Proprietary Medicine Modulates 5Α-Reductase Activity and Gene Expression Associated with Androgenetic Alopecia

Synergistic therapeutic effect of ginsenoside Rg3 modified minoxidil transfersomes (MXD-Rg3@TFs) on androgenic alopecia in C57BL/6 mice

Adipose Mesenchymal Stromal Cell-Derived Exosomes Carrying MiR-122-5p Antagonize the Inhibitory Effect of Dihydrotestosterone on Hair Follicles by Targeting the TGF-β1/SMAD3 Signaling Pathway

Increased Expression of Zyxin and Its Potential Function in Androgenetic Alopecia

Cyanidin-3-O-glucoside and its derivative vitisin A alleviate androgenetic alopecia by exerting anti-androgen effect and inhibiting dermal papilla cell apoptosis